Biotechnology Instruments Market Report 2026

Biotechnology Instruments Market Overview

• Biotechnology Instruments market size has reached to $80.9 billion in 2025 • Expected to grow to $111.27 billion in 2030 at a compound annual growth rate (CAGR) of 6.5% • Growth Driver: Fueled By The Rise Of Chronic Diseases • Market Trend: Advancements In Single-Cell Multi-Omics That Enhance Personalized Medicine And Research Through Innovative Biotechnology Instruments • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Biotechnology Instruments Market?

Biotechnology instruments refer to the specialized equipment and tools used in biotechnology laboratories to conduct research, develop products, and perform various biological processes. These instruments are essential for manipulating biological systems and organisms and facilitating advancements in medicine, agriculture, and environmental science. The main product types of biotechnology instruments are lab automation instruments, life science consumables, and in vitro diagnostic (IVD) instruments. Lab automation instruments are specialized devices designed to perform repetitive laboratory tasks with minimal human intervention. These are used in various applications such as clinical diagnostics, drug discovery and development, proteomics and genomics, cell analysis, and others, and also by various end-users such as pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, academic and research institutes, and others.

What Is The Biotechnology Instruments Market Growth Forecast?

The biotechnology instruments market size is expected to see strong growth in the next few years. It will grow to $111.27 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to development of advanced lab automation instruments, integration of ai and robotics in research workflows, expansion of genomics and proteomics studies, rising investment in pharmaceutical r&d, adoption of cloud-based data management solutions. Major trends in the forecast period include increasing adoption of lab automation instruments, rising demand for high-throughput screening and analysis, expansion of proteomics and genomics research, growing use of ivd instruments in clinical diagnostics, enhanced focus on quality control and regulatory compliance.

What Is The Driver Of The Biotechnology Instruments Market?

The prevalence of chronic diseases is expected to propel the growth of the biotechnology instruments market going forward. Chronic diseases, also known as chronic conditions or chronic illnesses, are health issues that persist for an extended period, typically lasting three months or longer. The prevalence of chronic diseases is due to unhealthy lifestyle choices, an aging population, and increased awareness and diagnosis. Biotechnology instruments help improve the quality of life for patients with chronic diseases by enhancing diagnosis accuracy, optimizing treatments, and enabling better disease management. They help identify potential drug candidates and understand their effects on chronic diseases. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the increasing demand for chronic diseases is driving the growth of the biotechnology instruments industry.

Key Players In The Global Biotechnology Instruments Market

Major companies operating in the biotechnology instruments market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Merck KGaA, Quest Diagnostics Inc., Avantor Inc., Agilent Technologies, Illumina Inc., Sartorius AG, Mettler Toledo, Perkin Elmer Inc., Shimadzu Corporation, Bruker Corporation, Zeiss Group, QIAGEN N.V., Novanta Inc., Cynosure LLC, Bio-Rad Laboratories Inc, Ori Biotech Limited, Hudson Robotics

Global Biotechnology Instruments Market Trends and Insights

Major companies operating in the biotechnology instruments market are focused on developing innovative products, such as single-cell multi-omics products, to enhance personalized medicine approaches and advance genomics, proteomics, and metabolomics research. Single-cell multi-omics products are advanced technologies that analyze multiple types of biological information from individual cells. These products integrate data from various omics layers such as genomics, transcriptomics, proteomics, and metabolomics. For instance, in June 2023, Singleron Biotechnologies, a Germany-based biotechnology company, launched two innovative instruments, the NEO and the Python Junior, to enhance the standardization of single-cell analysis workflows. The Neo system can process up to half a million cells in a single run across four independent channels, allowing for high throughput and flexibility in handling different applications simultaneously. The Python Junior instrument focuses on dissociating solid tissues into high-quality single-cell suspensions. It combines mechanical treatment and enzymatic digestion, enhancing the dissociation process's efficiency.

What Are Latest Mergers And Acquisitions In The Biotechnology Instruments Market?

In January 2024, Calibre Scientific, a US-based company specializing in manufacturing and supplying high-quality laboratory instruments, acquired LabTech S.r.l for an undisclosed amount. With this acquisition, Calibre Scientific aims to strengthen its position in the life sciences sector by expanding its portfolio of laboratory instruments and consumables. LabTech S.r.l is a UK-based company that manufactures biotechnology instruments such as centrifuges, shakers, incubators, and pipetting systems.

What Defines the Biotechnology Instruments Market?

The biotechnology instruments market consists of sales of micropipettes, incubators, and autoclaves. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Biotechnology Instruments Market Report 2026?

The biotechnology instruments market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biotechnology instruments industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.